Inside these posts: Consumer drug recalls

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.

 

Beset by recalls, J&J cuts CEO’s bonus 45%

Johnson & Johnson cut the 2010 performance bonus of its chief executive, William Weldon, by 45 percent, from 2009 levels to $1.98 million, according to a regulatory filing.

The CEO’s diminished bonus comes after a year in which the company faced repeated recalls of consumer health products, medical devices and other products that hit its bottom line. Get the full story »